Cardiovascular Final Report - Fall 2019 Cycle 

Cardiovascular disease (CVD) is a significant burden in the United States, leading to approximately one in four deaths per year. Considering the effect of CVD, measures that assess clinical care performance and patient outcomes are critical to reducing its negative impacts. These topic areas include primary prevention and screening, coronary artery disease (CAD), ischemic vascular disease (IVD), acute myocardial infarction (AMI), cardiac catheterization, percutaneous catheterization intervention (PCI), heart failure (HF), rhythm disorders, implantable cardioverter-defibrillators (ICDs), cardiac imaging, cardiac rehabilitation, and high blood pressure. On February 6, 2020, the Cardiovascular Standing Committee evaluated one newly submitted measure and six measures undergoing maintenance review against the National Quality Forum’s standard evaluation criteria. Due to changes to the commenting period to allow flexibility for organizations impacted by the COVID-19 pandemic, one maintenance measure was moved to the next evaluation cycle. This report details the evaluation of that measures, which was recommended for endorsement.